Search

EHA-SSH joint membership

Save money and time by becoming a joint member of EHA and the Swiss Society of Hematology. We've joined forces with the Swiss Society of Hematology (SSH) to offer a special joint membership deal.

EHA-THD joint membership

Save money and time by becoming a joint member of EHA and the Türk Hematoloji Derneği. We've joined forces with the Türk Hematoloji Derneği (THD) to offer a special joint membership deal.

Chairs and Members

ChairPaolo Gresele, Department of Medicine, Section of Internal and Cardiovascular Medicine, University of Perugia, Perugia (Italy)

Vice-ChairTo be announced.

Compliance and reports

EHA is a non-governmental and not-for-profit membership organization that is guided by its mission to promote excellence in patient care, research, and education in hematology.

Apply to be a Master Class mentor

Applications closed on July 15, 2024. There are two types of Master Class mentor: junior mentor and senior mentor. Before you apply, make sure you've read and understood the relevant eligibility criteria.

Apply to be a Master Class mentee

Applications closed on July 15, 2024

EligibilityTo apply to be a menteee, you must be one of the following:

A hematologist
Receiving hematology training
Seeing hematology patients
You must also be an EHA member.

Membership

Boost your career, fast-track your development, and make new connections by joining a pioneering European hematology organization with global reach.

Chairs and Members

Chair
Claire Harrison, Guy’s and St Thomas’ NHS Foundation Trust, Guy’s Hospital, London (United Kingdom)
Co-chair
Jean-Jacques Kiladjian, Hôpital Saint-Louis and Paris Diderot University, Paris (France)
SWG Steering Committee members
Alessandro Vannucchi, University of Florence (Italy)
Antonio Almeida, Hospital da Luz (Portugal)
Carlos Besses, Barcelona Biomedical Research…

EHA Research Conference 2025

Dates: March 17-20, 2025
Location: Málaga, Spain
Chairs: Alba Maiques Diaz, Ruud Delwel, Panagiotis Ntziachristos, Marcus Buschbeck, Mark Dawson,
Özgen Deniz, Kimberly Stegmaier, and Nina Cabezas Wallscheid

Registration is now open

EHA is proud to announce the third edition of the EHA Research Conference, titled "Transcriptional control and chromatin alterations in normal and abnormal hematopoiesis".…

I4MDS consortium: advancing MDS treatment and understanding

The role of the immune system in the pathophysiology of Myelodysplastic Neoplasms (MDS) is firmly established. However, routine immune monitoring for these patients is still not a common practice.